Breaking Bottlenecks in Life Sciences R&D with AI Innovation - with Aziz Nazha of Incyte Pharmaceuticals

Breaking Bottlenecks in Life Sciences R&D with AI Innovation - with Aziz Nazha of Incyte Pharmaceuticals

0 Anmeldelser
0
Episode
1125 of 1120
Længde
30M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

R&D teams are starting to advance AI capabilities faster than they can translate them into measurable business value, creating mounting friction between scientific progress and operational reality. In this episode, Aziz Nazha, Global Head of AI Innovations Institute at Incyte Pharmaceuticals, examines how culture, talent, infrastructure, and expectation‑setting determine whether AI meaningfully improves drug discovery and development. He highlights the practical shifts required — from redesigning workflows to disciplined upskilling and targeted validation cycles — to ensure AI adoption accelerates cycle times rather than getting stalled by organizational bottlenecks. This episode is sponsored by Deloitte. Learn how brands like Deloitte work with Emerj and other Emerj Media options at go.emerj.com/partner


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Breaking Bottlenecks in Life Sciences R&D with AI Innovation - with Aziz Nazha of Incyte Pharmaceuticals

Other podcasts you might like ...